Key Takeaways
- A dental practice EBITDA multiple is a negotiated outcome built from your specific financials, defended through diligence, and moved by competitive tension rather than a fixed table lookup.
- The earnings figure behind any quoted multiple must be confirmed, because SDE versus normalized EBITDA can produce dramatically different valuations on the same practice.
- Quality-of-earnings reviews can re-price owner compensation and challenge add-backs, which can move enterprise value by hundreds of thousands or more at typical multiples.
- Associate-led production, documented hygiene revenue, clean financials, stable staffing, and modern facilities are operating levers that can move a practice toward the top of its multiple band.
- McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis up front, runs both private-buyer and DSO/PE paths in roughly equal measure, and creates a structured competitive bid process that can lift valuations over going it alone.
What a Dental Practice EBITDA Multiple Really Represents
A dental practice EBITDA multiple is the factor applied to a practice’s normalized EBITDA, which means earnings before interest, taxes, depreciation, and amortization, adjusted to reflect what the practice earns under new ownership. Buyers use that product to estimate enterprise value. The multiple can vary by practice size, profitability, specialty, and buyer type, and it usually reflects fundamentals and negotiation rather than a published table. A quoted multiple only becomes meaningful once you know which earnings figure it applies to and how that figure was calculated.
The Problem: Why the Number You Were Quoted Is Probably Soft
A practice owner sells once in a career. An institutional buyer negotiates acquisitions every week. That information gap can be one of the main factors that determines what the owner walks away with.
When a single buyer, whether a neighboring dentist or a large DSO, presents a number first, that number becomes the anchor. Everything that follows is measured against it. A “free” valuation built on a rule of thumb instead of a documented earnings analysis compounds the problem. A weak valuation can get challenged in diligence and the deal can get re-traded, often after the seller has already signed a letter of intent and sent competing buyers home.
A single offer also produces no competitive tension. Talking to only one buyer forfeits the leverage of competing bids, and without competing bids, the price reflects only the buyer’s view of value.
The Solution: SDE vs. Normalized EBITDA as the Bridge to Your Multiple
The earnings figure underneath any multiple must be clear before you can evaluate an offer. Two metrics are commonly used in dental practice transactions, and they serve different buyer types.
Seller’s Discretionary Earnings (SDE) represents the total cash benefit available to a single working owner-operator. It starts with reported net income and adds back the owner’s salary, benefits, personal and discretionary expenses, interest, depreciation, amortization, and documented one-time items. Individual dentist buyers and smaller practices often use SDE because the buyer plans to perform the clinical work themselves.
Normalized EBITDA starts from that SDE figure and then subtracts a market-rate salary for the clinical dentistry the owner performs. In simple terms, it reflects what it would cost to hire a replacement dentist to do the same work. Larger practices, group buyers, and DSOs tend to use adjusted EBITDA because every dentist in their model draws a full clinical salary.
The following hypothetical example shows how this bridge works in practice. These figures are round numbers for educational purposes only and do not represent any specific practice or guaranteed outcome.
- Reported net income: $250,000
- Add back: owner W-2 salary ($200,000), owner benefits and personal vehicle ($30,000), depreciation and amortization ($40,000), interest on practice loans ($15,000), one-time equipment repair ($10,000)
- SDE: $545,000
- Subtract: market-rate replacement dentist cost ($260,000)
- Normalized EBITDA: $285,000
The same practice looks very different depending on which number a buyer applies their multiple to. Using the example above, a 5.0x multiple on $545,000 of SDE equals $2.725 million, while a 7.0x multiple on $285,000 of normalized EBITDA equals roughly $2.0 million. The higher headline multiple produces a lower price because it is applied to a smaller earnings base.
McLerran & Associates’ CPA-led process remotely accesses practice management software, cross-references reports against financials, and unpacks every add-back. That work builds a diligence-grade earnings analysis that can hold up when buyers look under the hood.

Schedule a Free Discovery Call
How Quality-of-Earnings Reviews Test Your Numbers
Once you understand which earnings figure a multiple applies to, the next risk involves what happens after you accept an offer. After a letter of intent (LOI) is signed, the buyer’s quality-of-earnings (QoE) team, a group of accountants hired specifically to stress-test the seller’s numbers, goes to work. The price stated in an LOI is typically non-binding, so a finding during diligence can be used to reopen and reduce it.
A buyer’s QoE review rebuilds earnings from source data instead of accepting the seller’s statements. The team restates anything that will not repeat under new ownership. The largest single adjustment is often the re-pricing of the owner’s clinical production. If a seller’s package credits $200,000 as the cost of replacing the owner’s clinical work but the buyer’s accountants price a replacement dentist at $330,000 from the production report, adjusted EBITDA can fall by $130,000. At an 8x multiple that change can move the price by more than $1 million.
An aggressive add-back schedule can collapse more than a conservative one that holds. When a third of a schedule falls over, the buyer’s accountants often re-examine everything already accepted. One undocumented finding can make the buyer reserve against surprises across the rest of the deal, which is the mechanism behind a re-trade.
McLerran & Associates defends the EBITDA it underwrote through the diligence process and reminds buyers that other vetted bidders remain in the process. That structure gives a seller going to market with the firm an advantage that is difficult to create alone.
The Levers That Move a Practice Up a Band
Specific operating and financial factors can move a practice toward the top or the bottom of any multiple range. Associate-led production, where the owner occupies less than 60–70% of chair time, is one of the highest-leverage de-risking variables in dental M&A and can add meaningfully to a practice’s multiple. When the owner produces most of the dentistry, buyers price in the risk that revenue walks out the door with the seller.
Other factors that can support a stronger multiple include:
- Hygiene revenue durability: Hygiene production at roughly 25–33% of collections with strong recall compliance can support the top of a valuation range. This pattern signals recurring, transferable revenue.
- Clean and well-organized financial reporting: Add-backs should be documented line by line with receipts and payroll records. When a seller presents a lump-sum add-back with no line-item backup, a buyer can challenge it and then question the rest of the schedule.
- Documented systems and staffing stability: A practice that runs beyond the owner, with stable long-tenured staff and documented operating procedures, reduces transition risk for any buyer.
- Facility and equipment condition: Deferred technology and equipment capital expenditure can signal a post-close upgrade cost that buyers deduct directly from enterprise value.
- Specialty and buyer demand: Oral and maxillofacial surgery can command some of the highest multiples and remains a fast-consolidating segment. Orthodontics and pediatric dentistry can draw strong institutional interest. General dentistry continues to earn aggressive, near-all-time-high valuations. Lighter-demand specialties tend to sit at the lower end of the range.
How Buyer Type Changes the Multiple and the Deal Structure
The same practice can receive meaningfully different offers depending on who is buying, and the differences often extend beyond the headline number.
A private dentist buyer usually prices a practice on collections or SDE, because they plan to perform the clinical work themselves. Private-buyer dental practice sales typically pay 100% cash at closing with a four-to-six-week seller transition. The buyer’s ceiling is set by what they can finance and what the practice’s cash flow supports after debt service. The structure is simpler, and the valuation ceiling is usually lower.
A DSO or private-equity-backed platform prices on adjusted EBITDA, after replacing the owner’s clinical pay at market rate. Rollover equity is effectively mandatory in DSO dental deals, typically 15–30% of total consideration, with the remainder in cash at close and sometimes an earnout tied to post-sale performance targets. In some structures equity can reach as much as 40% of the deal, which means the seller also becomes an investor in the platform and should evaluate it that way.
McLerran & Associates runs both paths in roughly equal measure, approximately 50/50, which gives owners a genuine side-by-side comparison instead of a guess. That approach creates a structural difference. An organization that affiliates practices with a single type of buyer will naturally orient its content and consulting that way. A sell-side-only advisor whose incentives are aligned exclusively with the selling dentist, and who runs a competitive auction among vetted buyers across both paths, can often produce a meaningfully different outcome for the seller.

What Is a Good EBITDA for a Dental Practice?
“Good” EBITDA is relative to practice size, specialty, overhead structure, and buyer type. An EBITDA margin of roughly 18–25% is a commonly cited benchmark for dental practices, though actual results can vary by specialty, overhead, and owner compensation adjustments. A practice collecting $2 million with 70% overhead is worth less than one collecting $1.5 million with 55% overhead. Buyers focus on profit margin rather than top-line collections.
A strong practice is one whose normalized EBITDA is durable and defensible, not just large. Headline dental practice multiples have held steady, but the gap between the best and middle offers has widened. Buyers now pay for proof: stable providers, strong hygiene recall, steady patient volume, and results that hold up in diligence.
The multiple for any given practice is determined by that practice’s specific numbers and market. A comprehensive, CPA-led valuation quantifies those details. General ranges exist, and where your practice falls within them depends on the mechanics described throughout this article.
How Competitive Tension Moves You Within the Band
Competitive tension can move a seller toward the top of their valuation band. A structured, auction-like process among a vetted, pre-qualified buyer pool produces a real market price. A dental practice marketed to only one buyer type is priced by only that group, while competition between buyer types is often where price is set.
McLerran & Associates’ DSO bid process typically runs approximately 45–60 days from launch and generates around 10 offers per listing. The field then narrows to finalists for in-person meetings. Poorly run DSOs are blacklisted and never reach the table. Clients typically see roughly a 30% higher valuation than selling alone. McLerran reports an approximately 85–90% transaction rate among its clients, versus an industry norm closer to 35–40%. Do-it-yourself close rates run approximately 15–20%.
The mechanism is straightforward. When a buyer knows other vetted bidders are waiting, a diligence finding becomes a conversation. When there is only one buyer, every finding becomes leverage.
How to Sanity-Check the Number You Were Quoted
Several simple checks can help you evaluate whether a quoted multiple rests on solid ground:
- Was the number built from your actual 3 years of financials, or from a rule of thumb applied to collections?
- Were add-backs documented line by line with receipts, payroll records, and invoices, or presented as a lump sum?
- Was owner compensation replaced at a documented market rate, or left in the earnings figure?
- How many buyers produced the number? One offer does not establish a market.
- Is any portion of the buyer’s number contingent on an earnout tied to post-sale performance targets you do not fully control?
- What happens if diligence finds a discrepancy between the seller’s add-back schedule and the source documents?
In one worked example, an owner’s pre-diligence working number was over $1.1 million, versus roughly $603,000 of adjusted EBITDA after the replacement-dentist bridge and disallowed add-backs. That gap of more than $500,000 of EBITDA, multiplied by a market multiple, represents the difference between what an owner thinks their practice is worth and what a buyer will actually pay.
Conclusion: Build and Defend the Number
Your dental practice EBITDA multiple is something you build and defend, not something you look up. A CPA-led, diligence-grade EBITDA analysis combined with a structured competitive bid process can move a seller toward the top of their band. A back-of-the-napkin number from a single buyer often struggles to survive diligence.
McLerran & Associates is a dental-specific sell-side M&A advisory for owners who want to maximize and defend their dental practice EBITDA multiple. The firm builds a CPA-led, diligence-grade EBITDA analysis up front, runs both private-buyer and DSO/PE paths in roughly equal measure, and creates a structured competitive bid process that can lift valuations over going it alone. With approximately 2,000 successful practice sales, roughly $2 billion in closed transaction volume, and more than 10,000 practices evaluated, the firm has the depth to control the narrative around your EBITDA and the buyer pool to make that narrative matter.

Owners considering a transition now or in the future can start the conversation early. Call (512) 900-7989, email info@dentaltransitions.com, or use the link below to schedule a free, confidential discovery call.
Get Your EBITDA Defended Before You Go to Market
Frequently Asked Questions
What Is a Good EBITDA for a Dental Practice?
“Good” EBITDA depends on practice size, specialty, overhead structure, and buyer type. As noted earlier, the commonly cited 18–25% margin can serve as a starting point, but the more important question is whether your EBITDA survives a buyer’s quality-of-earnings review. A practice with a smaller but well-documented, recurring EBITDA will often attract stronger offers than one with a larger but fragile or undocumented earnings base. EBITDA becomes compelling when it reflects what the practice genuinely earns under new ownership, after replacing the owner’s clinical pay at market rate and removing non-recurring items, and when it can pass a quality-of-earnings review without shrinking.
What Is the Best Way to Value a Dental Practice?
The most defensible approach uses a CPA-led, diligence-grade normalized-earnings analysis rather than a rule of thumb applied to collections. The process starts with 3 years of financial statements and tax returns, builds a documented SDE-to-normalized-EBITDA bridge with every add-back supported by receipts and payroll records, replaces owner compensation at a market clinical rate, and removes non-recurring items. That earnings figure is then tested against comparable market data and buyer-type economics. A collections-based rule of thumb can serve as a rough sanity check, but it ignores profitability entirely. Two practices collecting the same amount can be worth very different amounts depending on their overhead and earnings quality. A competitive process among multiple vetted buyers is what converts a strong valuation into a strong price.
How Does Owner Compensation Affect a Dental Practice’s EBITDA Multiple?
Owner compensation is the single largest normalization adjustment in the SDE-to-EBITDA bridge. In the bridge, the owner’s full compensation is first added back to reported earnings, and then a market-rate replacement dentist cost is subtracted. The net adjustment depends on what the owner has been drawing relative to what a replacement would cost. An owner who has been drawing well above market rate will see a meaningful upward adjustment to normalized EBITDA. An owner who has been drawing below market rate, often for tax-planning reasons, will see a downward adjustment. Because the multiple is applied to the resulting normalized EBITDA figure, a $30,000 change in the assumed replacement cost can move enterprise value by well over $100,000 at typical multiples. This dynamic explains why the owner-compensation normalization is often the most contested add-back in quality-of-earnings analysis and why documenting it with production records and a state and specialty benchmark is essential before going to market.
Do DSOs Pay Higher Multiples Than Private Buyers?
DSOs and private buyers price on different earnings bases and deal structures, so headline multiples are not directly comparable. A private dentist buyer prices on SDE, which keeps the owner’s full clinical pay in the earnings figure. A DSO prices on adjusted EBITDA, which resets owner compensation to a market-rate dentist salary. Because adjusted EBITDA is smaller than SDE for the same practice, the DSO’s headline multiple is correspondingly higher, but that difference does not automatically mean the DSO is paying more. The actual comparison depends on the earnings figure each multiple is applied to, the cash-at-close percentage, the terms of any rollover equity and earnout, the employment commitment required, and the financial health of the platform. A DSO deal can produce a higher total economic outcome for the right practice, or a lower one once structure is accounted for. Running both paths simultaneously and comparing them on an after-tax, present-value basis can clarify the tradeoffs.
What Is Normalized EBITDA in a Dental Practice?
Normalized EBITDA is the earnings a dental practice generates after replacing the owner’s clinical production at a market-rate dentist salary and removing documented non-recurring, personal, or discretionary expenses. It starts with reported net income, adds back interest, taxes, depreciation, and amortization, then adds back owner compensation and qualifying discretionary items, and finally subtracts the cost of hiring a replacement dentist to perform the clinical work the owner currently does. The result is an estimate of what the practice earns under new ownership, which is the figure a DSO or private-equity buyer usually applies their multiple to. It differs from SDE because SDE leaves the owner’s full compensation in the earnings figure, which is appropriate when the buyer will perform the clinical work themselves. Normalized EBITDA resets that compensation to a market rate, which is appropriate when the buyer must hire a replacement. Both measures can be useful, and the key is knowing which one a quoted multiple applies to.
Why Do Some Deals Get Re-Traded After the LOI?
A letter of intent typically contains a non-binding price, which means a buyer who finds something unexpected during diligence can use that finding to reopen and reduce the agreed number. Aggressive or unsupportable add-backs are among the most common causes of a post-LOI price cut, or “retrade,” in dental deals. Other common triggers include provider concentration, messy financials, short leases, compliance gaps, and credentialing delays. Items claimed without documentation, a replacement-dentist cost that was understated, or a “one-time” expense that recurs across multiple years can all raise concerns. A single undocumented finding also tends to make the buyer reserve against surprises across the rest of the deal, so one weak item can trigger a broader re-examination. The defense is preparation. A diligence-grade earnings analysis done before the deal goes to market, with every add-back supported by an invoice, payroll record, or signed engagement letter, leaves a buyer’s QoE team with little new to find and therefore less basis to reopen the price.
How Long Does a Competitive Sale Process Take?
McLerran & Associates’ DSO bid process typically runs approximately 45–60 days from launch to receipt of around 10 offers, after which the field narrows to finalists for in-person meetings or headquarters visits. From there, the process moves into letter of intent negotiation, diligence, and closing. The full engagement to close typically runs several months, depending on practice complexity, payor credentialing requirements, and the buyer’s own diligence timeline. Doctor-to-doctor transactions can move faster because they often involve simpler financing and diligence requirements. The preparation phase, which includes building the CPA-led valuation, assembling the data room, and preparing the marketing materials, happens before the formal process launches. Engaging an advisor well before a planned sale date can support better outcomes than starting the process under time pressure.